SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-161143
Filing Date
2014-04-28
Accepted
2014-04-28 07:18:06
Documents
4
Period of Report
2014-04-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d713590d8k.htm 8-K 16510
2 EX-99.1 d713590dex991.htm EX-99.1 10013
3 EX-99.2 d713590dex992.htm EX-99.2 32002
4 GRAPHIC g713590img1.jpg GRAPHIC 43529
  Complete submission text file 0001193125-14-161143.txt   119823
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 14787394
SIC: 2835 In Vitro & In Vivo Diagnostic Substances